Michel de Rosen
French businessman
Michel de Rosen (born February 18, 1951) is the chairman of Faurecia and was the CEO of Eutelsat Communications from 2009 to 2016. He is a non-executive member of the board of directors of ABB. He was chief executive officer and chairman of the board of directors of ViroPharma from August 2002 to May 2008. From 1982 to 1999, de Rosen held several positions at Rhône-Poulenc (France) and Rhone-Poulenc Rorer (USA) (now Sanofi-Aventis), including chief executive officer from May 1995 until December 1999, and chairman of the board of directors from 1996 to 1999.
Career
From 1976 to 1982 de Rosen was auditor at the French Ministries of Finance and Defense.
Education
Michel de Rosen holds a Master of Business Administration from HEC Paris.
Organizations
Michel de Rosen is or has been on a number of boards:
ABB (director, since 2002);
Aspen Institute (mentor)
Global Business Coalition on HIV/AIDS (director)
Gnosko Bio (advisor, since 2020)
HTH Worldwide (advisor)
InnaPhase Corporation (director, July 2000 - September 2004)
Pennsylvania Bio (director)
Ursinus College (trustee)
In an interview with the British newspaper The Sunday Telegraph on October 8, 1995, he was quoted as saying that he ... sees RPR as a mixture of 'hunting' – growing the company by swooping on acquisition 'prey' – and 'farming', less glamorous but vital organic growth and development of new drugs.
The public source identifies “Michel de Rosen” as french businessman. This brief keeps that definition visible, then builds a research path around Michel, Rosen and French.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Michel de Rosen”, the useful work is to connect “french businessman” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Sep 14, 2026. The linked authority identifier is Q3311206. VIAF identifies the subject as 49244143. The Library of Congress control number is n85379994. 3 of 3 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1951, 2009, 2016 and 2002.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Michel de Rosen”, its source revision and the description used here.
- Expand the search: follow Michel de Rosen primary sources, Michel de Rosen archive and Michel research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Michel de Rosen”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Michel de Rosen” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.